SCOPUS 정보 검색 플랫폼

Annals of Neurology

Volumn 68, Issue 1, 2010, Pages

4-Aminopyridine: New life for an old drug

(2) Hauser, Stephen L a Johnston, S Claiborne a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; DALFAMPRIDINE; PLACEBO; UNCLASSIFIED DRUG;

COST BENEFIT ANALYSIS; DECISION MAKING; DRUG COST; DRUG FORMULATION; DRUG RELEASE; EDITORIAL; HEALTH CARE COST; HEALTH HAZARD; HEALTH INSURANCE; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

4-AMINOPYRIDINE; ANIMALS; CLINICAL TRIALS AS TOPIC; DELAYED-ACTION PREPARATIONS; HUMANS; MULTIPLE SCLEROSIS; OFF-LABEL USE; POTASSIUM CHANNEL BLOCKERS;

EID: 77954077611 PISSN: 03645134 EISSN: 15318249 Source Type: Journal
DOI: 10.1002/ana.22118 Document Type: Editorial

Times cited : (16)

References (9)

1
- 60649090430
- Sustained-release oral fampridine in multiple sclerosis: A randomized, double blind controlled trial
- Goodman AD, Brown TR, Krupp LB, et al. Sustained-release oral fampridine in multiple sclerosis: a randomized, double blind controlled trial. Lancet 2009;373:732-38.
- (2009) Lancet , vol.373 , pp. 732-738
- Goodman, A.D.¹ Brown, T.R.² Krupp, L.B.³

2
- 0018840887
- Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres
- Sherratt RM, Bostock H, Sears TA. Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibers. Nature 1980;283:570-2. (Pubitemid 10136031)
- (1980) Nature , vol.283 , Issue.5747 , pp. 570-572
- Sherratt, R.M.¹ Bostock, H.² Sears, T.A.³

3
- 0020508919
- Effects of 4-aminopyridine in patients with multiple sclerosis
- Jones RE, Heron JR, Foster DH, et al. Effects of 4-aminopyridine in patients with multiple sclerosis. J Neurol Sci 1983;60:353-62.
- (1983) J Neurol Sci , vol.60 , pp. 353-362
- Jones, R.E.¹ Heron, J.R.² Foster, D.H.³

4
- 0023134727
- 4-Aminopyridine improves clinical signs in multiple sclerosis
- DOI 10.1002/ana.410210113
- Stefoski D, Davis FA, Faut M, et al. 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol 1987;21:71-7. (Pubitemid 17004147)
- (1987) Annals of Neurology , vol.21 , Issue.1 , pp. 71-77
- Stefoski, D.¹ Davis, F.A.² Faut, M.³ Schauf, C.L.⁴

5
- 0026719595
- The effect of 4-aminopyridine on clinical signs in multiple sclerosis: A randomized placebo-controlled, double-blind, cross-over study
- van Diemen HAM, Polman CH, van Dongen TMMM et al. The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized placebo-controlled, double-blind, cross-over study. Ann Neurol 1992;32:123-30.
- (1992) Ann Neurol , vol.32 , pp. 123-130
- Van Diemen, H.A.M.¹ Polman, C.H.² Van Dongen, T.M.M.M.³

6
- 0030989459
- Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis
- Schwid SR, Petrie MD, McDermott MP, et al. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurol 1997;48:817-21.
- (1997) Neurol , vol.48 , pp. 817-821
- Schwid, S.R.¹ Petrie, M.D.² McDermott, M.P.³

7
- 33845997749
- Financial anatomy of neuroscience research
- Dorsey ER, Vitticore P, De Roulet J, et al. Financial anatomy of neuroscience research. Ann Neurol 2006;60:652-9.
- (2006) Ann Neurol , vol.60 , pp. 652-659
- Dorsey, E.R.¹ Vitticore, P.² De Roulet, J.³

8
- 33846089338
- A status report on neuroscience research without grade inflation
- Johnston SC, Hauser SL. A status report on neuroscience research without grade inflation. Ann Neurol 2006;60:9A.
- (2006) Ann Neurol , vol.60
- Johnston, S.C.¹ Hauser, S.L.²

9
- 62549099078
- Comparative effectiveness research in the neurosciences
- Johnston SC, Hauser SL. Comparative effectiveness research in the neurosciences. Ann Neurol 2009;65:11A.
- (2009) Ann Neurol , vol.65
- Johnston, S.C.¹ Hauser, S.L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.